Saturday 17 October 2026
Export KRMD’s income statement to Excel — free account
KORU Medical Systems, Inc.
KRMD Healthcare Medical Instruments & Supplies
KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
3.00
0.03
−0.99%
Follow KRMD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (10.52%) | (13.70%) | (15.58%) | (21.71%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 5 | 5 | |
| (6.81%) | (8.17%) | (9.52%) | (13.62%) | ||
ROIC |
(10.50%) | (19.76%) | (22.51%) | (30.91%) | |
Return on Tangible Assets |
(11.19%) | (14.18%) | (16.22%) | (23.46%) | |
Average Days of Receivables |
49.30 | 53.31 | 57.95 | 51.52 | |
Free Cash Flow per Share |
0.01 | 0.00 | (0.01) | 0.00 | |
Free Cash Flow |
0.25 | 0.12 | (0.49) | (0.17) | |
Capital Expenditures |
(1.14) | (0.59) | (0.95) | (0.48) | |
| Other line items | |||||
Cash ROIC |
0.95% | 0.47% | (1.87%) | (0.68%) | |
Accounts Receivable Turnover |
8.07 | 6.87 | 6.57 | 7.27 | |
Accounts Payable Turnover |
8.46 | 7.08 | 7.93 | 8.31 | |
Inventory Turnover |
4.01 | 4.25 | 4.79 | 3.53 | |
Average Days of Payables |
62.73 | 58.42 | 53.32 | 46.42 | |
Days of Inventory on Hand |
97.15 | 99.22 | 86.48 | 109.39 | |
Tax Rate |
0.02 | 0.00 | 2.09 | 1.40 | |
Research and Development Expense of Revenue |
9.90% | 10.61% | 10.67% | 11.15% | |
Selling, General and Administrative Expense of Revenue |
54.44% | 55.49% | 56.84% | 59.29% | |
Share Based Compensation of Revenue |
6.07% | 6.24% | 6.60% | 6.25% | |
Operating CF/Net income |
(0.76) | (0.31) | (0.18) | (0.08) | |
Depreciation/Fixed assets |
0.20 | 0.18 | 0.18 | 0.20 | |
Capex/Depreciation |
(1.44) | (0.75) | (1.17) | (0.57) | |
Revenue per Share |
0.98 | 0.93 | 0.89 | 0.85 | |
Operating CF per Share |
0.03 | 0.02 | 0.01 | 0.01 | |
Capex per Share |
(0.02) | (0.01) | (0.02) | (0.01) | |
Capex to Sales |
0.03 | 0.01 | 0.02 | 0.01 |
Columns are period end dates